AIIMS Delhi develops mobile apps to deal with mental illness

New Delhi: The All India Institute of Medical Sciences (AIIMS) in Delhi has developed two mobile apps for patients suffering from chronic mental illness and their caretakers.

As the whole world is reeling under the Covid-19 pandemic, cases of anxiety and depression have gone up.

AIIMS has developed two mobile apps to deal with severe mental illness for patients suffering from chronic mental illness and for those who got the first episode of such symptoms. The two apps – ‘Shaksham’ and ‘Disha’ – are for both who undergoes first such episode of symptoms and for those having severe mental illness.

Mamta Sood, senior psychiatrist at AIIMS, told IANS, “We have developed two mobile apps — Shaksham and Disha — to deal with mental illness.”

She added that the Shaksham app is for those suffering from chronic mental illness, while the Disha app will benefit persons who undergo first such episode of symptoms.

Both the apps have been developed in collaboration with the computer science departments of Indraprastha Institute of Technology, Delhi, and the University of Warwick, UK. The project was funded by the National Institute of Health Research, UK.

“The apps will be available for free public use from January next year. We are more concerned about the patient data to be used in the apps and once the data restoration is secured, we will launch it by January next year,” Sood said.

“The apps will also send reminder to the care givers for medicines and other requirements of the patients,” she added.

Asked about the mental problems faced by people during the ongoing pandemic, Sood said that an AIIMS research conducted on healthcare workers has revealed that 50 per cent of the healthcare workforce are facing symptoms like anxiety, depression and stress.

However, she added that having such symptoms and having the disease are different, as symptoms do not affect the patients, while disease affects all.

  • Related Posts

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    New Delhi: Serious legal gaps in the Drugs and Cosmetics Act, 1940, combined with acute shortages of manpower and infrastructure, continue to impede the Central Drugs Standard Control Organisation (CDSCO)…

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna: In a significant ruling that could have far-reaching implications for NDPS drug-related prosecutions involving common pharmaceutical compounds, the Patna High Court has held that Phenothiazine and Promethazine do not…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines